>What of AustraliaMarket too small and still a lengthy process...

>What of Australia
Market too small and still a lengthy process to get approval from TGA. In other words: For a comparable amount of time & money spent - you may as well go for Europe than Australia.

> and the USA?
Longer process than with EU, but it is in the pipeline.


I propose an alternative reason for the delay, from the announcement from last month:

BSI has further advised the Company that the review by MHRA will take up to 30 calendar days,
plus any additional days necessary for questions to the Company and for Tissue Therapies’ staff to reply to MHRA.

My major concern is that an as yet unknown competitor could also be launching a similar product and is running 'interference' on our launch. Its a concern, and I'm just throwing it out there, not saying that it is actually the case. I am not concerned about a different ASX listed company (whose name I can't remember) - and no this is not an invitation to cross promote your stock on this thread.